Biotech company develops novel immunotherapies targeting the dark genome to enhance natural cancer-fighting capabilities.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Mnemo Therapeutics is a biotechnology company that develops immunotherapies by identifying novel tumor-specific targets from the unexploited dark genome. By leveraging a combination of in-silico and wet-lab pipelines, it aims to improve the body’s ability to detect and eradicate cancer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Mnemo Therapeutics Management Team
Mnemo Therapeutics Valuations & Financials
View real-time NPM data on Mnemo Therapeutics stock including daily Mnemo Therapeutics stock price estimates, valuation history, and historical share price information. Access Mnemo Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Mnemo Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Mnemo Therapeutics? Get in touch to learn more.
Similar Companies
like Mnemo Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Skild AI
AI & Machine Learning
Develops a versatile AI platform for robotics to automate tasks and address labor shortages.
ExecThread
Media & Entertainment
Premium vetted executive network that crowdsources and shares unpublished senior-level job opportunities discreetly among members.
Influ2
Enterprise Software
Targets decision-makers with tailored ads across major platforms, tracks engagement, and aligns marketing efforts with sales to drive revenue.
TripleBar
Healthcare & Life Sciences
Creates products that nourish, heal, and sustain both people and the planet.
Flower Ave
Media & Entertainment
Develops anonymous social networking apps that facilitate location-based interactions for users seeking community engagement.
Delfi Diagnostics
Healthcare & Life Sciences
Utilizes artificial intelligence and whole genome sequencing to detect unique patterns of DNA fragmentation in the blood of cancer patients.
Massive Bio
Healthcare & Life Sciences
Matches patients to clinical trials using AI and personalized medical data analysis.
FAQ
We have answers
Mnemo Therapeutics stock does not trade on public stock exchanges. Mnemo Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Mnemo Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Mnemo Therapeutics Stock does not trade on public stock exchanges. In order to sell Mnemo Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Mnemo Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Mnemo Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Mnemo Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Mnemo Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Mnemo Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Mnemo Therapeutics is a private company and has not had an IPO. There is currently no Mnemo Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Mnemo Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
